PerpEquities

Equity

Iovance Biotherapeutics, Inc. (IOVA) perpetual futures

IOVA perpetual futures on 1 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade IOVAUSDT.

Iovance Biotherapeutics is a biotech firm developing cancer immunotherapies that use patients' own immune cells, with several Phase 2 trials for melanoma, cervical, and head and neck cancers.

$14.28-0.1%NASDAQ open
Open in terminal

Price chart

Interactive TradingView chart

TradingView symbol NASDAQ:IOVA

Loads TradingView's third-party widget (about 1 MB) on demand.

Auto: underlying reference priceOpen in TradingView

Trading data

Perpetual market activity

1/1 live markets
Venues
1
Live markets
1/1
24h volume
$255.1K
Open interest
-Coverage: 0/1 markets
Best liquidity
$34.3K
BingX
Tightest spread
+21.0 bps
BingX
Highest volume
$255.1K
BingX
Settlement mix
USDT · 1/1
Perp/spot vol.
0.00x
Spot volume $78.3M
OI / float
-
Float $5.5B
Spot performance
1D-0.31%
5D-3.27%
1M+61.22%
6M+329.43%
YTD+419.10%
1Y+541.24%

Venue matrix

1 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
BingXTradeIOVA-USDTTrading$14.28-4.4% APR
-0.00400% every 8h
+21.0 bps$34.3K$255.1K-USDT-

Tradability

Execution quality

Entry cost and depth per venue at $1k–$100k

Thin liquidity · 1 of 1 venues absorb $10k · Typical cost: +44.3 bps

Cheapest execution: BingX · +44.3 bps

Taker execution estimate incl. approx. fees - maker fills are not guaranteed.

Best venues for this underlying

Best liquidity

IOVA

Tightest spread

IOVA

Highest volume

IOVA

Funding history

Stored venue snapshots by market

Company data

Company fundamentals

Updated 55m ago
Market cap
$6.4B
Updated 55m ago
Revenue
$325M
Trailing 12 months
Revenue growth
+56%
Next fiscal year
Profit margin
-89.1%
P/E
-20.3
Peer P/E -1.6
Free cash flow
-$296.4M
Trailing 12 months
More metrics
Net income
-$289.5M
Trailing 12 months
P/S
19.5
Peer P/E
-1.6
Similar listed perps
Revenue estimate
$411.2M
Next fiscal year
Earnings
2026-11-05
Revenue est. $114.1M · Updated 55m ago
Dividend
-

Fundamental detail

Annual + quarterly
Latest revenue$263.5M
Net margin-148.4%
Free cash flow-$336.2M
Net debt-$114.6M
2020$0
2021$0
2022$0
2023$1.2M
2024$164.1M
2025$263.5M
PeriodRevenueGrowthNet incomeFCF
2020$0--$259.6M-$251.9M
2021$0--$342.3M-$265.5M
2022$0--$395.9M-$313.2M
2023$1.2M--$444M-$384.1M
2024$164.1M+13,699%-$372.2M-$364M
2025$263.5M+61%-$391M-$336.2M
PeriodGross marginOperating marginNet marginROEROA
20200.0%0.0%0.0%-39.5%-33.8%
20210.0%0.0%0.0%-55.1%-44.0%
20220.0%0.0%0.0%-79.2%-59.6%
2023-804.5%-38,735.0%-37,345.4%-76.0%-56.9%
2024+24.4%-240.9%-226.8%-52.4%-40.9%
2025+97.2%-153.1%-148.4%-56.0%-42.8%
PeriodCashDebtNet debtCurrent ratio
2020$67.3M$51.7M-$15.7M11.59
2021$78.2M$71.5M-$6.7M5.69
2022$231.7M$85.4M-$146.3M5.24
2023$114.9M$75.9M-$39M2.79
2024$115.7M$58.3M-$57.4M3.74
2025$163.1M$48.4M-$114.6M3.20
PeriodMarket capEnterprise valueP/SP/E
2020$6.4B$6.4B0.0-24.7
2021$2.9B$2.9B0.0-8.6
2022$1B$871.4M0.0-2.6
2023$1.9B$1.9B1,607.8-4.3
2024$2.1B$2.1B13.1-5.8
2025$975.6M$860.9M3.7-2.5
Q3 2024$58.6M
Q4 2024$73.7M
Q1 2025$49.3M
Q2 2025$60M
Q3 2025$67.5M
Q4 2025$86.8M
Q1 2026$71.4M
Q2 2026$99.3M
PeriodRevenueGrowthNet incomeFCF
Q3 2024$58.6M+12,385%-$83.5M-$61.3M
Q4 2024$73.7M+15,189%-$78.6M-$77.5M
Q1 2025$49.3M+6,798%-$116.2M-$109.9M
Q2 2025$60M+93%-$111.7M-$74.9M
Q3 2025$67.5M+15%-$91.3M-$89.5M
Q4 2025$86.8M+18%-$71.9M-$61.9M
Q1 2026$71.4M+45%-$79M-$78.7M
Q2 2026$99.3M+66%-$47.3M-$66.3M
PeriodGross marginOperating marginNet marginROEROA
Q3 2024+32.0%-152.1%-142.7%-10.8%-8.4%
Q4 2024+38.2%-117.5%-106.6%-11.1%-8.6%
Q1 2025-0.8%-245.8%-235.5%-15.1%-12.0%
Q2 2025+5.5%-189.8%-186.2%-16.0%-12.3%
Q3 2025+97.9%-140.7%-135.3%-13.0%-10.1%
Q4 2025+215.9%-84.7%-82.9%-10.3%-7.9%
Q1 2026+98.6%-113.5%-110.7%-11.0%-8.5%
Q2 2026+54.6%-52.3%-47.6%-6.4%-5.2%
PeriodCashDebtNet debtCurrent ratio
Q3 2024$164.2M$78.9M-$85.2M4.22
Q4 2024$115.7M$58.3M-$57.4M3.74
Q1 2025$171.7M$53.7M-$117.9M4.18
Q2 2025$132.5M$53.2M-$79.3M3.27
Q3 2025$158.1M$52.5M-$105.6M3.41
Q4 2025$163.1M$48.4M-$114.6M3.20
Q1 2026$196.5M$47.8M-$148.7M3.60
Q2 2026$110.8M$46M-$64.8M4.35
PeriodMarket capEnterprise valueP/SP/E
Q3 2024$2.8B$2.8B48.6-8.4
Q4 2024$2.3B$2.2B30.6-7.1
Q1 2025$1.1B$957.2M21.8-2.3
Q2 2025$575.4M$496.1M9.6-1.3
Q3 2025$790M$684.3M11.7-2.2
Q4 2025$1.1B$996.4M12.8-4.6
Q1 2026$1.5B$1.3B20.6-4.6
Q2 2026$1.9B$1.8B18.9-9.5

Refreshed 55m ago

Charts: revenue, profit, cash flow & valuation
Revenue$99.3MQ2 2026
$24.8M$49.7M$74.5M$99.3MQ3 2023: $469KQ4 2023: $482KQ1 2024: $715KQ2 2024: $31.1MQ3 2024: $58.6MQ4 2024: $73.7MQ1 2025: $49.3MQ2 2025: $60MQ3 2025: $67.5MQ4 2025: $86.8MQ1 2026: $71.4MQ2 2026: $99.3MQ3 2023Q2 2026
Net income-$47.3MQ2 2026
-$87.3M-$58.2M-$29.1MQ3 2023: -$113.8MQ4 2023: -$116.4MQ1 2024: -$113MQ2 2024: -$97.1MQ3 2024: -$83.5MQ4 2024: -$78.6MQ1 2025: -$116.2MQ2 2025: -$111.7MQ3 2025: -$91.3MQ4 2025: -$71.9MQ1 2026: -$79MQ2 2026: -$47.3MQ3 2023Q2 2026
EBITDA-$39.2MQ2 2026
-$81.3M-$54.2M-$27.1MQ3 2023: -$105.1MQ4 2023: -$108.4MQ1 2024: -$104.5MQ2 2024: -$87.7MQ3 2024: -$77.9MQ4 2024: -$65.3MQ1 2025: -$106.9MQ2 2025: -$97.7MQ3 2025: -$84.7MQ4 2025: -$67.8MQ1 2026: -$71.2MQ2 2026: -$39.2MQ3 2023Q2 2026
Free cash flow-$66.3MQ2 2026
-$94.8M-$63.2M-$31.6MQ3 2023: -$87.7MQ4 2023: -$87.5MQ1 2024: -$126.5MQ2 2024: -$98.9MQ3 2024: -$61.3MQ4 2024: -$77.5MQ1 2025: -$109.9MQ2 2025: -$74.9MQ3 2025: -$89.5MQ4 2025: -$61.9MQ1 2026: -$78.7MQ2 2026: -$66.3MQ3 2023Q2 2026
EPS-$0.11Q2 2026
-$0.35-$0.23-$0.11Q3 2023: -$0.46Q4 2023: -$0.45Q1 2024: -$0.42Q2 2024: -$0.34Q3 2024: -$0.28Q4 2024: -$0.26Q1 2025: -$0.36Q2 2025: -$0.33Q3 2025: -$0.25Q4 2025: -$0.15Q1 2026: -$0.19Q2 2026: -$0.11Q3 2023Q2 2026
Cash / Debt$110.8MQ2 2026
$66.9M$133.9M$200.8M$267.7MQ3 2023 · Cash: $267.7MQ3 2023 · Debt: $79.5MQ4 2023 · Cash: $114.9MQ4 2023 · Debt: $75.9MQ1 2024 · Cash: $134.2MQ1 2024 · Debt: $84.4MQ2 2024 · Cash: $228.8MQ2 2024 · Debt: $81.7MQ3 2024 · Cash: $164.2MQ3 2024 · Debt: $78.9MQ4 2024 · Cash: $115.7MQ4 2024 · Debt: $58.3MQ1 2025 · Cash: $171.7MQ1 2025 · Debt: $53.7MQ2 2025 · Cash: $132.5MQ2 2025 · Debt: $53.2MQ3 2025 · Cash: $158.1MQ3 2025 · Debt: $52.5MQ4 2025 · Cash: $163.1MQ4 2025 · Debt: $48.4MQ1 2026 · Cash: $196.5MQ1 2026 · Debt: $47.8MQ2 2026 · Cash: $110.8MQ2 2026 · Debt: $46MQ3 2023Q2 2026
CashDebt
Profitability+54.6%Q2 2026
-18,873.7%-12,510.5%-6,147.3%+215.9%Q3 2023 · Gross margin: -825.4%Q4 2023 · Gross margin: -805.6%Q1 2024 · Gross margin: -915.5%Q2 2024 · Gross margin: -0.8%Q3 2024 · Gross margin: +32.0%Q4 2024 · Gross margin: +38.2%Q1 2025 · Gross margin: -0.8%Q2 2025 · Gross margin: +5.5%Q3 2025 · Gross margin: +97.9%Q4 2025 · Gross margin: +215.9%Q1 2026 · Gross margin: +98.6%Q2 2026 · Gross margin: +54.6%Q3 2023 · Operating margin: -25,236.9%Q4 2023 · Operating margin: -25,156.8%Q1 2024 · Operating margin: -16,464.6%Q2 2024 · Operating margin: -327.6%Q3 2024 · Operating margin: -152.1%Q4 2024 · Operating margin: -117.5%Q1 2025 · Operating margin: -245.8%Q2 2025 · Operating margin: -189.8%Q3 2025 · Operating margin: -140.7%Q4 2025 · Operating margin: -84.7%Q1 2026 · Operating margin: -113.5%Q2 2026 · Operating margin: -52.3%Q3 2023 · Net margin: -24,255.9%Q4 2023 · Net margin: -24,145.0%Q1 2024 · Net margin: -15,800.8%Q2 2024 · Net margin: -312.2%Q3 2024 · Net margin: -142.7%Q4 2024 · Net margin: -106.6%Q1 2025 · Net margin: -235.5%Q2 2025 · Net margin: -186.2%Q3 2025 · Net margin: -135.3%Q4 2025 · Net margin: -82.9%Q1 2026 · Net margin: -110.7%Q2 2026 · Net margin: -47.6%Q3 2023Q2 2026
Gross marginOperating marginNet margin
Revenue growth+65.7%Q2 2026
+3,797.3%+7,594.6%+11,391.9%+15,189.2%Q3 2024: +12,384.9%Q4 2024: +15,189.2%Q1 2025: +6,798.5%Q2 2025: +92.7%Q3 2025: +15.2%Q4 2025: +17.7%Q1 2026: +44.8%Q2 2026: +65.7%Q3 2023Q2 2026
Shares outstanding450.2MQ2 2026
112.5M225.1M337.6M450.2MQ3 2023: 245.8MQ4 2023: 256MQ1 2024: 266.2MQ2 2024: 284.8MQ3 2024: 303.3MQ4 2024: 304.9MQ1 2025: 322.9MQ2 2025: 334.5MQ3 2025: 364MQ4 2025: 407MQ1 2026: 418.5MQ2 2026: 450.2MQ3 2023Q2 2026
Valuation-9.5Q2 2026
1,313.82,637.03,960.25,283.4Q3 2023 · P/E: -2.5Q4 2023 · P/E: -4.5Q1 2024 · P/E: -8.4Q2 2024 · P/E: -5.9Q3 2024 · P/E: -8.4Q4 2024 · P/E: -7.1Q1 2025 · P/E: -2.3Q2 2025 · P/E: -1.3Q3 2025 · P/E: -2.2Q4 2025 · P/E: -4.6Q1 2026 · P/E: -4.6Q2 2026 · P/E: -9.5Q3 2023 · P/S: 2,384.8Q4 2023 · P/S: 4,317.2Q1 2024 · P/S: 5,283.4Q2 2024 · P/S: 73.8Q3 2024 · P/S: 48.6Q4 2024 · P/S: 30.6Q1 2025 · P/S: 21.8Q2 2025 · P/S: 9.6Q3 2025 · P/S: 11.7Q4 2025 · P/S: 12.8Q1 2026 · P/S: 20.6Q2 2026 · P/S: 18.9Q3 2023Q2 2026
P/EP/S
Revenue$263.5M2025
$65.9M$131.8M$197.6M$263.5M2018: $02019: $02020: $02021: $02022: $02023: $1.2M2024: $164.1M2025: $263.5M20182025
Net income-$391M2025
-$333M-$222M-$111M2018: -$123.6M2019: -$197.6M2020: -$259.6M2021: -$342.3M2022: -$395.9M2023: -$444M2024: -$372.2M2025: -$391M20182025
EBITDA-$357.1M2025
-$310.8M-$207.2M-$103.6M2018: -$122.6M2019: -$189.4M2020: -$260.8M2021: -$328.3M2022: -$371.8M2023: -$414.4M2024: -$331.4M2025: -$357.1M20182025
Free cash flow-$336.2M2025
-$288.1M-$192.1M-$96M2018: -$102.4M2019: -$165.8M2020: -$251.9M2021: -$265.5M2022: -$313.2M2023: -$384.1M2024: -$364M2025: -$336.2M20182025
EPS-$1.092025
-$1.87-$1.25-$0.622018: -$1.272019: -$1.52020: -$1.882021: -$2.232022: -$2.492023: -$1.892024: -$1.282025: -$1.0920182025
Cash / Debt$163.1M2025
$57.9M$115.9M$173.8M$231.7M2018 · Cash: $82.2M2018 · Debt: $02019 · Cash: $14M2019 · Debt: $11.5M2020 · Cash: $67.3M2020 · Debt: $51.7M2021 · Cash: $78.2M2021 · Debt: $71.5M2022 · Cash: $231.7M2022 · Debt: $85.4M2023 · Cash: $114.9M2023 · Debt: $75.9M2024 · Cash: $115.7M2024 · Debt: $58.3M2025 · Cash: $163.1M2025 · Debt: $48.4M20182025
CashDebt
Profitability+97.2%2025
-29,026.9%-19,318.9%-9,610.8%+97.2%2018 · Gross margin: 0.0%2019 · Gross margin: 0.0%2020 · Gross margin: 0.0%2021 · Gross margin: 0.0%2022 · Gross margin: 0.0%2023 · Gross margin: -804.5%2024 · Gross margin: +24.4%2025 · Gross margin: +97.2%2018 · Operating margin: 0.0%2019 · Operating margin: 0.0%2020 · Operating margin: 0.0%2021 · Operating margin: 0.0%2022 · Operating margin: 0.0%2023 · Operating margin: -38,735.0%2024 · Operating margin: -240.9%2025 · Operating margin: -153.1%2018 · Net margin: 0.0%2019 · Net margin: 0.0%2020 · Net margin: 0.0%2021 · Net margin: 0.0%2022 · Net margin: 0.0%2023 · Net margin: -37,345.4%2024 · Net margin: -226.8%2025 · Net margin: -148.4%20182025
Gross marginOperating marginNet margin
Revenue growth+60.6%2025
+3,424.7%+6,849.5%+10,274.2%+13,699.0%2024: +13,699.0%2025: +60.6%20182025
Shares outstanding357.3M2025
89.3M178.7M268M357.3M2018: 97.3M2019: 124.3M2020: 138.3M2021: 153.4M2022: 159.3M2023: 235.1M2024: 289.9M2025: 357.3M20182025
Valuation-2.52025
383.4791.51,199.61,607.82018 · P/E: -7.02019 · P/E: -18.52020 · P/E: -24.72021 · P/E: -8.62022 · P/E: -2.62023 · P/E: -4.32024 · P/E: -5.82025 · P/E: -2.52018 · P/S: 0.02019 · P/S: 0.02020 · P/S: 0.02021 · P/S: 0.02022 · P/S: 0.02023 · P/S: 1,607.82024 · P/S: 13.12025 · P/S: 3.720182025
P/EP/S

Next catalyst

Catalysts

Earnings
2026-11-05
Revenue est. $114.1M · Updated 55m ago

No unusual perp activity right now.

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 2026-0.45$411.2M+56%6
FY 2027-0.21$575.2M+118%6
FY 20280.17$881.7M+235%5
FY 20290.27$1.1B+322%1
FY 20300.52$1.4B+438%1
Q3 2026-0.09$114.1M+69%5

Company events

6
2026-11-05EarningsActual - / Estimate -0.09-
2026-08-06EarningsActual -0.11 / Estimate -0.13Beat
2026-05-07EarningsActual -0.19 / Estimate -0.19In line
2026-02-24EarningsActual -0.18 / Estimate -0.22Beat
2025-11-06EarningsActual -0.25 / Estimate -0.29Beat
2025-08-07EarningsActual -0.33 / Estimate -0.29Miss

Peer comparison

Similar listed perps

Analyst track record

How the analysts covering IOVA have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings54220
Analysts1422
Buy / hold / sell45 / 7 / 2196 / 21 / 3
Upgrades / downgrades / initiations1 / 0 / 11 / 6 / 3
Price targets hit / missed42 / 9 (82%)66 / 131 (34%)
Avg. return after a rating (TipRanks)+93.3%+28.3%
Best / worst call+848.7% / -28.9%+1,323.0% / -58.2%

After buy calls on this stock: median 21-day move -5.6% vs S&P 500 -8.7% (n = 202)

Most accurate on this stock

Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.

  1. Yanan ZhuWells Fargo29% hit rate on this stock · 21 targets measuredBuytarget $18.00Sep 30, 2026
  2. Peter LawsonBarclays28% hit rate on this stock · 18 targets measuredBuytarget $4.00Nov 4, 2025
  3. Joseph PantginisH.C. Wainwright0% hit rate on this stock · 19 targets measuredBuytarget $20.00Sep 29, 2026

Latest ratings

DateAnalystCallTarget
Sep 30, 2026Yanan ZhuWells FargoBuyReiterated$18.00
Sep 30, 2026Yanan ZhuWells FargoBuyMaintained$18.00
Sep 29, 2026Etzer DaroutBarclaysBuyMaintained$15.00
Sep 29, 2026Joseph PantginisH.C. WainwrightBuyReiterated$20.00
Sep 30, 2026Joseph PantginisH.C. WainwrightBuyReiterated$20.00
Consensus over the last 12 months buy hold sell avg. target month-end close
Monthly buy, hold and sell shares of analyst ratings with the average price target and the month-end close$2.00$4.00$6.00$8.00$10.00$12.00$14.00Nov 25 · Buy 7 · Hold 2 · Sell 1Nov 25Dec 25 · Buy 6 · Hold 2 · Sell 1Jan 26 · Buy 6 · Hold 1 · Sell 1Jan 26Feb 26 · Buy 7 · Hold 2 · Sell 1Mar 26 · Buy 8 · Hold 3 · Sell 1Mar 26Apr 26 · Buy 8 · Hold 3 · Sell 1May 26 · Buy 7 · Hold 3 · Sell 1May 26Jun 26 · Buy 8 · Hold 3 · Sell 1Jul 26 · Buy 8 · Hold 3 · Sell 1Jul 26Aug 26 · Buy 8 · Hold 2 · Sell 0Sep 26 · Buy 9 · Hold 2 · Sell 0Sep 26Oct 26 · Buy 9 · Hold 2 · Sell 0Nov 25 · avg. target $8.44Dec 25 · avg. target $8.64Jan 26 · avg. target $8.64Feb 26 · avg. target $7.78Mar 26 · avg. target $7.64Apr 26 · avg. target $7.64May 26 · avg. target $7.80Jun 26 · avg. target $8.00Jul 26 · avg. target $8.00Aug 26 · avg. target $9.50Sep 26 · avg. target $12.45Oct 26 · avg. target $12.45Nov 25 · month-end close $2.47Dec 25 · month-end close $2.73Jan 26 · month-end close $2.55Feb 26 · month-end close $3.86Mar 26 · month-end close $3.51Apr 26 · month-end close $3.36May 26 · month-end close $4.10Jun 26 · month-end close $4.16Jul 26 · month-end close $4.07Aug 26 · month-end close $8.17Sep 26 · month-end close $14.82Oct 26 · month-end close $14.22

Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.

TipRanks data via FMP · computed Oct 2, 2026 · 54 ratings

Frequently asked questions

Where can I trade IOVA perpetual futures?

Iovance Biotherapeutics, Inc. (IOVA) perpetual futures trade on 1 crypto venues, including BingX. PerpEquities compares them by live price, funding rate, open interest and liquidity.

Can I trade IOVA around the clock?

Yes. Unlike the underlying stock, IOVA perpetuals trade 24/7 — including weekends and outside regular market hours.

What is the funding rate on IOVA perpetuals?

Right now the IOVA perp funding rate is -4.4% annualized (venue median), ranging from -4.4% to -4.4% across 1 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.

How does the IOVA perp price compare to the Iovance Biotherapeutics, Inc. stock?

The venue-median IOVA perp mark is $14.3 versus a reference stock price of $14.3, a basis of 0.0%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.

What is a IOVA perpetual future?

A IOVA perpetual is a derivative that tracks the price of Iovance Biotherapeutics, Inc. with no expiry date. It lets you take long or short exposure to Iovance Biotherapeutics, Inc. on crypto venues, around the clock.

What is IOVAUSDT perpetual?

IOVAUSDT is the symbol most crypto exchanges use for the Iovance Biotherapeutics, Inc. perpetual settled in USDT (Tether). It tracks the IOVA share price through an index, trades 24/7 with leverage and never expires.

Embed this asset

IOVA perpetuals · perpequities.comIOVA perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/iova-perp"><img src="https://perpequities.com/badge/iova-perp.svg" width="240" height="64" alt="IOVA perpetuals · perpequities.com" loading="lazy"></a>

Next step

Stay on top of IOVA perps

Signals with a track record

Analysts who hit 70%+ of their targets on the perps we track, congress buys over $500k, 13F positions over $5M, funding spreads that have paid for days. Every post shows the evidence. Free, no sign-up.

Join on Telegram

Weekly digest by email

The listings, funding and moves that matter for IOVA — one email every Sunday.

Watchlist and alerts

Price and funding alerts for IOVA, via push or Telegram.

Set an alert

Follow the live feed

Daily movers, new listings and funding extremes as they happen.

Follow on X